|9 Months Ended|
May 31, 2020
|Marketable Securities [Abstract]|
20. Marketable Securities
The components of Marketable Securities were as follows:
During the period ended May 31, 2020 common stock with a cost basis of $25,000, received from a licensee in lieu of cash, was sold for $6,802 realizing an $18,198 loss.
Unrealized losses from common stock are due to market price movements. Management does not believe any remaining unrealized losses represent other-than-temporary impairments based on our evaluation of available evidence. The COVID-19 pandemic has caused significant market turbulence and it is possible that our evaluation will change dependant upon new information as it arises.
The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef